Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: Expression, design optimization, uptake mechanism and nuclear localization by Seow, WY et al.
6276–6289 Nucleic Acids Research, 2009, Vol. 37, No. 18 Published online 19 August 2009
doi:10.1093/nar/gkp651
Oligopeptide-mediated gene transfer into mouse
corneal endothelial cells: expression, design
optimization, uptake mechanism and
nuclear localization
Wei Yang Seow1,2, Yi-Yan Yang1,* and Andrew J. T. George2,*
1Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, Singapore 138669, Singapore and
2Department of Immunology, Faculty of Medicine, Imperial College London, Hammersmith Hospital,
Du Cane Road, London, W12 ONN, UK
Received June 21, 2009; Revised and Accepted July 21, 2009
ABSTRACT
Gene transfer to the corneal endothelium has poten-
tial in preventing corneal transplant rejection. In this
study, we transfected mouse corneal endothelial
cells (MCEC) with a class of novel arginine-rich
oligopeptides. The peptides featured a tri-block
design and mediated reporter gene expression
in MCEC more efficiently than the commercial
polyethylenimine standard. The functionality of
each block was demonstrated to critically influence
the performance of the peptide. Results from con-
focal imaging and flow cytometry then showed that
energy-dependent endocytosis was the dominant
form of uptake andmultiple pathways were involved.
Additionally, uptake was strongly dependent on
interactions with cell-surface heparan sulphate.
Fluorescence resonance energy transfer studies
revealed that the peptide/DNA entered cells as an
associated complex and some will have dissociated
by 8.5 h. Large-scale accumulation of uncondensed
DNAwithin the nucleus can also be observed by 26h.
Finally, as a proof of biological relevance, we
transfected MCEC with plasmids encoding for the
functional indoleamine 2,3-dioxygenase (IDO)
enzyme. We then demonstrated that the expressed
IDO could catalyse the degradation of L-tryptophan,
which in turn suppressed the growth of CD4+ T-cells
in a proliferation assay.
INTRODUCTION
The cornea is an immune privileged tissue, in large part
due to its avascular nature and the scarcity of dendritic
cells in the corneal graft, although other factors also
contribute to its status (1,2). This privilege, while not
absolute, explains the high success rate that first-time cor-
neal grafts routinely enjoy even in the absence of systemic
immunosuppression (2). Nonetheless, allograft failure still
occurs and around a quarter of grafts will fail within 5
years (3,4). Immune rejection is the biggest cause for this
graft loss and is especially prevalent among recipients with
previous episodes of graft rejection, inflammation or
neovascularization (5). There is therefore an urgent need
for novel forms of therapy and the ex vivo delivery of
immunomodulatory genes into the cornea prior to trans-
plantation represents one promising strategy to allow long
term survival of the graft (6,7).
The cornea, specifically, its posterior endothelial
monolayer which fulfils the critical function of
maintaining corneal transparency (8), is particularly
amenable to such a genetic approach because of its
accessibility, simple anatomy and its ability to be
stored and manipulated ex vivo for up to a month
before surgery (8). The ex vivo immunomodulation of
corneal transplantation is thus a realistic goal as it
avoids many of the challenges associated with gene
delivery at the systemic level. To achieve this objective,
viral vectors, for example, adenovirus (9,10), lentivirus
(11), equine infection anaemia virus (12), recombinant
adeno-associated virus and herpes simplex virus (13),
among others, have been explored actively. The biggest
advantage of viral mediated gene delivery is the natural
efficiency of viruses at infecting and transferring genetic
cargoes into cells. However, most viral systems are
limited by their innate immunogenicity, proinflam-
matory nature, cytotoxicity, limited cargo loading cap-
acity and the complexity of industrial scale production
(5). As a result, non-viral vectors may be a safer alter-
native for clinical applications (14), although their
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efficiency is lower and the gene expression they mediate
is more transient than some viral vectors.
Oligopeptides as a class of non-viral vector has recently
gained prominence. Advantages of such a system include
their biodegradability, biocompatibility and ease of pro-
duction and compositional control. Current oligopeptide
designs are based mainly on cationic arginine (15) or
lysine (16) to achieve DNA binding effects. To further
improve transfection efficiency, either hydrophobic
moieties (17–19) or endosomolytic agents (20–23) are fre-
quently incorporated.
Recently, we explored a novel class of non-viral vector
made from natural amino acids which combined all the
above features (24). The peptides had a tri-block design
comprising of arginine for DNA binding and membrane
penetration, histidine for buffering effects and a segment
of hydrophobic residues for enhancing cellular uptake and
DNA binding ability (Figure 1). We demonstrated that
they could bind and protect DNA from enzymatic
degradation. Importantly, the peptides mediated efficient
reporter gene expression in a variety of cell lines and,
more significantly, following injection into mice bearing
solid tumours. While the systemic application of these
peptides is limited due to the large size (up to 50 mm)
of the peptide/DNA complexes (24), they can still have a
role in the ex vivo manipulation of corneas and other
tissues or cells.
In this study, we explored the possibility of using these
peptides to transfect mouse corneal endothelial cells
(MCEC). We showed that the peptides were able to trans-
fect MCEC more efficiently than polyethylenimine (PEI),
a commercially available transfection reagent (25). We
systematically demonstrated that the functionality of
each block in the peptide design was essential to achieve
high transfection. We then investigated the pathways of
endocytosis and intracellular trafficking followed by these
vectors. Fluorescence resonance energy transfer (FRET)
was also used to investigate the events occurring between
early internalization and eventual nuclear localization.
Finally, to demonstrate the biological relevance of this
system, we transfected MCEC with plasmids encoding
for the functional indoleamine 2,3-dioxygenase (IDO)
enzyme. We showed in a functional assay that the
expressed IDO could catalyse the breakdown of
tryptophan, an amino acid T-cells critically depend on
for growth. Consequently, their growth was retarded in
a proliferation assay involving CD4+ T-cells and IDO-
transfected MCEC. This study therefore provides a
useful platform from which we can develop the ex vivo
manipulation of whole corneas.
MATERIALS AND METHODS
Materials
Nocodazole, cytochalasin D, dynasore, sodium azide,
2-deoxyglucose, methyl-b-cyclodextrin, filipin III, 5-(N-
ethyl-N-isopropyl)amiloride (EIPA), heparin, chloro-
quine, branched polyethylenimine (Mw 25 000 g/mol)
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-
bromide (MTT) were all purchased from Sigma
(Singapore) and were of the highest purity available.
Transferrin-AlexaFluor488, cholera toxin-AlexaFluor488,
dextran-Texas Red (10 000 g/mol, neutral overall charge)
and Hoechst 34580 were from Invitrogen (Singapore).
Label IT CyTM5, CyTM3 and TM-rhodamine labelling
kits were from Mirus (Madison, WI, USA). Reporter
genes used were either the 6.4 kb firefly luciferase
(pCMV-luciferase VR1255C) driven by the cytomegalo-
virus promoter (Carl Wheeler, Vical, San Diego, CA,
USA) or the 4.7 kb GFPmut1 variant (pEGFP-C1)
driven by the SV40 early promoter (Clontech, Palo Alto,
CA, USA). For a therapeutic gene, the 8.5 kb pSMART-
2G plasmid was used encoding IDO under control of
the cytomegalovirus promoter. The cell line used was
the SV40-immortalized BALB/c strain MCEC (12). All
peptides were synthesized as reported previously with
a purity >96% according to high performance liquid
chromatography (HPLC) (24).
In vitro luciferase and GFP expression
MCEC was maintained in Dulbecco’s modified Eagle’s
medium (DMEM) completed with 10% (v/v) fetal
bovine serum, 1% (v/v) non-essential amino acids,
100 mg/ml of streptomycin and 100U/ml of penicillin at
378C with 5% CO2. Cells were seeded 1 day before
experiments. For the luciferase transfection assay, 0.5ml
of medium containing 6.0 104 cells were seeded into each
well of a 24-well plate, while for the GFP transfection
assay, 1.0ml of medium containing 1.8 105 cells were
pipetted into each well of a 12-well plate.
Peptide complexes were formed at various N/P ratios
(defined here as the molar ratio of arginine to the DNA
phosphorus content) by the drop-wise addition of
equivolume solutions of peptide into DNA. Ten
millimolar phosphate buffer (pH 7.0) was used to form
the particles for all experiments unless otherwise stated.
The desired N/P ratios were achieved by fixing the amount
of DNA used and varying the amount of peptide. The
mixture was then vortexed for 10 s and left to stand
for 30min before use. PEI/DNA complexes were simi-
larly formed either in water or 10mM phosphate buffers.
However, only data for PEI/complexes formed in water
were presented as this formulation gave higher luciferase
expression results. All media was replaced before the solu-
tion containing the complexes was added drop-wise into
each well. Full-serum conditions were always maintained
throughout transfection unless otherwise stated. The
media was again replaced after 4 h of incubation.
Analysis for luciferase expression was carried out after
3 days. Cells were washed with 0.5ml of PBS before the
addition of 0.2ml of ‘Reporter Lysis Buffer’ (Promega,
Madison, WI, USA). Membrane lysis was completed
with two freeze–thaw cycles and manual cell scratching
between the cycles. The cell suspension was centrifuged
at 20 800 g for 10min. The supernatant (20 ml) was
removed and mixed with 100 ml of a luciferase assay
reagent (Promega). The relative light unit (RLU) was
measured with a luminometer (Lumat LB 9507, Mandel
Scientific, Ontario, Canada) and protein concen-
tration with a bicinchoninic acid protein assay kit
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(Pierce, Rockfort, IL, USA). Luciferase activity was
expressed as RLU per milligram proteinSD of at least
four samples.
For the GFP transfection assay, cells were harvested
after 2 days, washed three times with 1.0ml of PBS and
detached with 0.3ml of trypsin (0.5 g/l in PBS). The cell
suspension was then centrifuged at 20 800g for 10min,
followed by resuspension in a dilute trypsin solution
(0.2 g/l) to further digest and remove any surface-bound
peptide complexes. The cell pellet was again collected and
finally resuspended in PBS for analysis using a flow
cytometer (FACSCalibur, BD Bioscience, San Jose, CA,
USA). A total of 10 000 events were recorded and percent-
age of MCEC expressing GFP was reported as a
mean SD of at least four samples. Cells were defined
to be GFP positive by setting the gating region to include
1% of cells mock transfected with plasmids encoding for
luciferase.
Uptake studies
Uptake of complexes into MCEC was either measured
using flow cytometry or imaged by confocal microscopy.
In both cases, plasmids encoding for luciferase were
labelled with Cy5 according to the manufacturer’s
recommendation, followed by ethanol precipitation. The
labelling density was determined to be about 1 Cy5 dye
per 135 base pairs by absorbance at 649 and 260 nm.
One day before the experiment, cells were either seeded
into 12-well plates at 2.2 105 cells per well or confocal
chambers (Nunc, Rochester, NY, USA) at 1.2 105 cells
per chamber. Peptide complexes were then formed with
the Cy5-labelled DNA and added to the cells. After 3 h
of incubation at 378C, cells were washed thoroughly and
either harvested for flow cytometry analysis (3-laser LSR
II, BD Bioscience) as described above, or stained with the
Hoechst nuclear dye for confocal imaging (LSM 5 DUO,
Carl Zeiss, Jena, Germany). The parameter used to quan-
tify uptake in flow cytometry was the mean fluorescence
intensity from 10 000 gated cells. Cells transfected with
unlabelled DNA were used as negative controls.
Inhibitor studies
The effects of various inhibitors were assessed at both
the uptake and luciferase expression level. Depending
on the experiment, cells were pre-incubated with one of
the following inhibitors for 1 h before transfection: noco-
dazole (4.5 mg/ml) (26), cytochalasin D (5.0 mg/ml) (27),
dynasore (6.8 mg/ml) (28), sodium azide (0.5mg/ml) with
2-deoxyglucose (4.1mg/ml) (26), methyl-b-cyclodextrin
(5.2mg/ml) (29), filipin III (1.0 mg/ml) (26), EIPA (25mg/
ml) (29). Inhibitors that had limited water solubility were
first dissolved in DMSO to make a stock solution. The
cells were then replaced with fresh growth media
containing the respective inhibitors before addition of
peptide complexes (N/P 20) containing either fluorescently
labelled or unlabelled DNA encoding for luciferase. No
pre-incubation was carried out for experiments involving
heparin (50 mg/ml) (30) or chloroquine (100mM) (31),
which was present in the media only during transfection.
All inhibitor solutions were 0.22mm filtered before use.
Analyses by flow cytometry and confocal microscopy
were performed 3 h later, while luciferase expression was
quantified 72 h later, as described above. All data were
presented relative to control cells transfected in the pres-
ence of vehicle control (DMSO or water) alone (100%).
Toxicity induced by the various inhibitors was accounted
for in preliminary experiments where a suitable working
concentration was established for which cell death was not
evident.
Co-localization with endocytosis markers
Cells were concurrently incubated with peptide complexes
(N/P 20) containing DNA labelled with TM-rhodamine
and one of the following markers for specific endocytosis
pathways: transferrin-AlexaFluor488 (25 mg/ml), cholera
toxin-AlexaFluor488 (5 mg/ml) and dextran-Texas Red
(10 mM). After 30–40min, the cells were extensively
rinsed with PBS, stained with Hoechst and immediately
imaged using confocal microscopy. Z-stacking was done
to confirm that signals originate from within the cells in all
confocal experiments in this study.
FRET
Plasmids encoding for luciferase were double-labelled
with Cy3 and Cy5 (approximately 1.5 Cy3 dye: 1 Cy5
dye: 100 base pairs of the plasmid). On the day of
experiment, peptide complexes (N/P 20) containing the
double-labelled DNA were incubated with the cells for
2 h at 378C, followed by extensive washing with PBS.
The cells were then returned to the incubator followed
by live cell analysis at selected time points. During
imaging, Cy3 was excited with the 543 nm laser. Cy5
would only be excited if there was FRET. Both the
emissions of Cy3 (560-615 nm band-pass) and Cy5
(650 nm long-pass) were collected in the experiments.
FRET images were then quantified with Matlab R2006
ver7.2.0.232 by binary-scoring each pixel as  for fluo-
rescence. The ratio of Cy5-positive to Cy3-positive pixels
was used to indicate the extent of FRET for that image.
Heparin displacement assays
Peptide complexes were first formed at N/P ratio 20 and
then incubated with heparin (0.1 to 20.0mg/ml) for 1 h at
room temperature (228C). Agarose gel electrophoresis
(80V, 50min) with ethidium bromide staining was used
to detect DNA released by heparin treatment. DNA still
bound to peptide was either seen within the loading well
or was not visible due to the inability of ethidium bromide
to intercalate condensed DNA.
Titration experiments
To compare the relative buffering capacity of the peptides,
titration was carried out with an automatic potentiometric
titrator (AT-610, Kyoto Electronics Manufacturing,
Tokyo, Japan) against 0.01M NaOH. The temperature
was maintained at 258C by a circulating water bath and
the electrodes were calibrated with standards before use.
A 16ml of peptide solution (0.5mg/ml) was used for all
titration experiments.
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IDO mRNA expression
The expression of IDO was first quantified at the mRNA
level using RT–PCR. MCEC cultured in 12-well plates
were exposed to either peptide F or PEI complexed to
plasmids encoding for IDO for 4 h, as per earlier
experiments. LipofectamineTM2000 (Invitrogen) was also
used at a ratio of 1 : 2.5 (DNA : lipofectamineTM2000)
according to the manufacturer’s protocol. Cells were
harvested 48 h post-transfection and their RNA isolated
for reverse-transcription into cDNA. Samples were then
analysed using the Sybr-Green PCR Mastermix (Applied
Biosystem, Warrington, UK) and a 7900 HT Fast Real
Time PCR system (Applied Biosystems). The thermal
profile used was: stage 1, initial denaturation, 958C for
10min; stage 2, amplification, 958C for 15 s, 608C for
1min, 728C for 30 s for 40 cycles and stage 3, dissociation,
958C for 15 s, 608C for 15 s, 958C for 15 s. Specificity of
the amplification was confirmed by the observation of a
single dissociation peak from the samples. IDO mRNA
expression was normalized to hypoxanthine phos-
phoribosyl transferase (HPRT) mRNA. Primers used for
IDO and HPRT have been described elsewhere (12).
Western blot
Cells were transfected in 24-well plates and then lysed 48 h
later by resuspension in Laemmli reducing sample buffer
(Sigma, UK). Protein lysates were resolved on a 12%
SDS–polyacrylamide gel and then blotted onto a nitrocel-
lulose membrane. Anti-mouse IDO mAb (MAB5412,
Chemicon, CA, USA) or anti-b-actin mAb (Sigma) was
used as a primary probe, followed by HRP-conjugated
rabbit anti-mouse antibody (P0161, DakoCytomation,
UK). Blots were developed using the Lumigen PS-3
(Lumigen, MI, USA) system.
L-kynurenine functional assay
The biological activity of the expressed IDO was
determined by colorimetrically measuring the levels of
L-kynurenine, the metabolic product of tryptophan. Cells
were cultured in 24-well plates and the media was
supplemented with 200 mM of tryptophan. Cells were
either transfected with peptide F (IDO), mock-transfected
(GFP) or untransfected for 4 h. Where appropriate,
1-methyl-DL-tryptophan (1-MT) (Sigma) was added at a
final concentration of 0.75mM to inhibit the activity of
IDO. The level of L-kynurenine in the culture supernatant
was then quantified 48-h post-transfection. Briefly, 100 ml
of culture supernatant was incubated with 100 ml of 30%
trichloroacetic acid (Sigma) at 508C for 30min in a 96-well
plate. The precipitated protein was then spun down and
100 ml of the clear supernatant was transferred to a new
96-well plate for incubation with 100 ml of freshly prepared
Ehrlich’s reagent at 658C for 15min. Absorbance was then
measured at 492 nm with a spectrophotometer (Anthos
Labtec HT 2, Salzburg, Austria). A calibration curve
(R2> 0.99) was generated with samples of known
L-kynurenine concentration.
T-cell proliferation assay
CD4+ responder T-cells were freshly isolated from the
spleens of C3H mice using procedures described elsewhere
(12). 105 T-cells (stimulated with anti-CD3 and CD28
beads) were then added to each well of a 96-well plate
already containing 5 104 MCEC (treated with 40 mg/ml
of mitomycin C for 30min) which were either
untransfected or transfected with peptide F complexed
with plasmids encoding for IDO or GFP. Where
appropriate, 1-MT was added at a final concentration
of 0.75mM. After 3 days of co-incubation, 30 ml of
[3H]thymidine solution (1 mCi/well, Amersham
Pharmacia Biotech, UK) was added. The amount of
incorporated radioactivity was measured 16 h later
with a 1450 MicroBeta TriLux (PerkinElmer, Shelton,
CT, USA).
RESULTS AND DISCUSSION
The peptides have a tri-block design (Figure 1) in which
the arginine sequence was used for DNA binding, the
histidine block for buffering capacity and the hydrophobic
segment for enhancing uptake and DNA-binding ability.
We carried out initial experiments to determine if each
of these blocks was necessary.
The octaarginine block serves to bind DNA and there-
fore is a necessary component of the design. Furthermore,
the length of eight repeat units had previously been
optimized in terms of its ability to deliver the reporter
gene encoding for luciferase into COS-7 cells (17).
To determine if the hydrophobic block was important,
we synthesized a series of peptides (Table 1), each
containing a hydrophobic block made up of amino
acids with varying degree of hydrophobicity: NH2-
I5H4R8-CONH2 (I), NH2-F5H4R8-CONH2 (F), NH2-
W5H4R8-CONH2 (W), arranged in order of decreasing
hydrophobicity (32,33). As a control, we also removed
the hydrophobic segment in one of the sequences, i.e.
NH2-H4R8-CONH2 (H), and then evaluated all peptides
in terms of their ability to mediate luciferase expression in
MCEC. As shown in Figure 2a, there was a dependence
on N/P ratio for expression efficiency. Removing the
hydrophobic block resulted in a drastic reduction (more
than four orders) in the amount of luciferase expressed
by the cells across the entire range of N/P ratios tested.
H4 for buffering R8 for DNA binding
F5 for cellular uptake
and complex formation
Figure 1. Design features of the oligopeptide vectors with (1)
octaarginine for DNA binding and membrane penetration, (2) histidine
residues for buffering capacity and (3) a hydrophobic segment (shown
as F5) for enhancing cellular uptake and DNA complex formation.
Colour scheme: red, O; white, H; grey, C; blue, N.
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This clearly demonstrates the importance of the hydro-
phobic block in achieving high transfection levels.
Additionally, significant differences in expression level
were also observed by varying the degree of hydrophobi-
city of the peptides. W, the least hydrophobic, resulted in
the least expression, while F and I performed comparably
within the range of N/P ratios tested. Encouragingly, both
F and I were superior to PEI—widely regarded as one of
the most efficient non-viral vectors available (25)—in
terms of luciferase expression. The length of the hydro-
phobic block was also optimized as peptide F mediated
significantly more luciferase expression then complexes
formed with NH2-F2H4R8-CONH2 (F2) or NH2-
F8H4R8-CONH2 (F8) (Figure 2b). Lower N/P ratios
were excluded from the diagrams because of poor
efficiency. For instance, the expression levels achieved
for F at N/P 5 and 10 were 1% and 5% of that achieved
at N/P 15, respectively.
The presence of hydrophobic groups within a vector has
been reported to increase transfection (25,34), and one
reason proposed may be due to the stabilization of the
complex (35,36). To test for this, we conducted a heparin
displacement assay in which H and F complexes were first
formed at N/P 20 and then incubated with a range of
heparin concentrations for 1 h. Displacement of DNA
by the anionic heparin was detected by gel electrophoresis
(37,38). As shown in Figure 2c, a heparin concentration
of 1mg/ml was sufficient to completely displace the
DNA condensed by H. F complexes, on the other hand,
remained stable up till a concentration of 20mg/ml.
Similarly, complexes of I and W were also stable up to
20mg/ml of heparin (data not shown), showing that the
presence of a hydrophobic block results in complexes that
are more resistant to heparin displacement. It should be
noted that while a more stable complex would be better
at protecting the DNA from degradation, it may also pre-
vent intracellular release of the DNA thus limiting its
bioavailability. However, the latter possibility does not
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Figure 2. Effects of the hydrophobic block on the properties of the oligopeptide vectors. (a) Luciferase expression levels in MCEC transfected with
W5H4R8 (W), F5H4R8 (F), I5H4R8 (I), H4R8 (H) or PEI complexes and (b) F2H4R8 (F2) F5H4R8 (F) or F8H4R8 (F8) complexes. (c) Heparin
displacement assay with H/DNA and F/DNA complexes incubated with increasing concentrations of heparin for 1 h at room temperature. Naked
DNA served as the positive control. (d) Relative uptake quantified with flow cytometry after MCEC have been transfected with either peptide H,
F or W complexed to Cy5-labelled DNA. The negative control refers to MCEC transfected with F/unlabelled DNA at N/P 20. All error bars
represent SD.
Table 1. A summary of the nature of hydrophobic segment and length
of hydrophobic histidine, glycine or arginine blocks used for all
peptides in this study
Peptide Hydrophobic
block
Hydrophobic
(length)
Histidine
(length)
Arginine
(length)
I Isoleucine 5 4 8
F Phenylalanine 5 4 8
W Tryptophan 5 4 8
H – 0 4 8
F2 Phenylalanine 2 4 8
F8 Phenylalanine 8 4 8
H8 Isoleucine 5 8 8
G4 Isoleucine 5 4 (Glycine) 8
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seem to be of a major concern as F complexes still
mediated significantly higher expression levels than H.
The presence of hydrophobic moieties has also been
reported to improve cellular uptake (39,40). To investigate
this, H and F peptides were used to deliver Cy5-labelled
DNA encoding for luciferase into MCEC. For this
experiment, cells were exposed to the respective complexes
for 3 h at 378C before washing and analysis. Using the
mean fluorescence intensity as a parameter, results from
flow cytometry showed that F complexes were internalized
about eight times more efficiently than H complexes
(Figure 2d). This trend was also consistent with our pre-
vious results which indicated that F complexes were
internalized about 13 times more efficiently than H
complexes by HEK293 cells (24). Additionally, F
complexes were also more efficiently internalized than W
complexes and this may be one possible factor for the
higher luciferase expression achieved with the former. As
a negative control, cells were also transfected with F
complexes (N/P 20) containing unlabelled plasmids to
show that the difference in mean fluorescence detected
was due to DNA uptake and not novel protein expression
or other nonspecific effects of transfection. The adequate
removal of surface-adsorbed particles was proved by
incubating the cells with sodium azide/2-deoxyglucose
(NaN3/DOG), which inhibited energy-dependent endo-
cytosis but not surface binding (41). This reduced the
mean fluorescence near to background (see later results).
The observation that F complexes were more readily
internalized than H complexes was further corroborated
with confocal observations where brightly fluorescent cells
were detected upon exposure to F complexes containing
Cy5-labelled DNA (Supplementary Figure S1). In sharp
contrast, little fluorescence was detected in cells exposed
to H complexes. As above, the addition of NaN3/DOG
blocked the internalization of F complexes (see later
results). Z-stacking also confirmed the absence of signals
throughout the entire thickness of the cell layer,
demonstrating the efficient removal of surface-bound
particles.
While it is clear that the hydrophobic group provided
for greater complex stability, cellular penetration and
transfection, the actual mechanism responsible for these
effects remains to be explained. We note that the size of
F complexes upon DNA binding was 15–50 mm [peptides
with other hydrophobic groups, e.g. I, W and G showed
similar size distribution up to N/P 30 (data not shown)],
while H/DNA complexes were 0.8–2.0 mm (24). It is pos-
sible that the hydrophobic moieties may have caused the
aggregation and precipitation of complexes onto the
cell layer for a more direct contact. In turn, this may
boost the internalization and transfection achieved with
F complexes compared to H complexes. Although the
contribution of precipitation cannot presently be
ascertained, it is still noteworthy that the luciferase expres-
sion level mediated by F complexes was on average more
than two orders higher than that achieved using calcium
phosphate (Supplementary Figure S2), a system known to
efficiently transfect cells by precipitation (42). This justifies
the further development of these peptides. Moreover,
the transfection mediated by F complexes was also more
than two orders higher than that achieved with W
complexes (Figure 2a), despite both having comparable
size. This argues that precipitation alone is not sufficient
to ensure high transfection and that other aspects of
the molecular design are important. Current efforts in
our lab are on the elucidation of the effects of the hydro-
phobic block.
We next investigated whether the buffering histidine
block is a useful component of the design. The imidazole
sidegroup of histidine has a pKa 6.0 and as such, is suited
to disrupt endosomal vesicles by proton scavenging effects
under the proton sponge hypothesis (31,43,44). To directly
test for the influence of the histidine block on the buffering
capacity, we synthesized additional peptide sequences in
which the length of the histidine block was either increased
to 8, i.e. NH2-I5H8R8-CONH2 (H8), or totally replaced
with non-functional glycine spacers, i.e. NH2-I5G4R8-
CONH2 (G4). We then compared the pH profile of
peptides I, H8 and G4 upon titration against a standard
solution of dilute sodium hydroxide (0.01M). Figure 3a
indicates that a larger amount of base was needed to cause
a unit increase in pH of H8, followed by I and then by G4.
This confirms that a larger buffering capacity can be
achieved with a longer histidine block and most probably
explains why I transfected significantly better than G4
(Figure 3b). The presence of a buffering histidine block
is thus an important design consideration.
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Figure 3. Effects of the buffering histidine block on the properties of the oligopeptide vectors. (a) Titration experiments with 16ml of de-ionized
water (DI) containing 0.5mg/ml peptide (G4, I or H8) or nothing (DI) against 0.01M NaOH. (b) Luciferase expression levels in MCEC transfected
with peptide/DNA complexes with varying length and nature of the buffering block. Error bars represent SD.
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However, as also observed by others (45), a larger
buffering capacity does not necessarily result in greater
transfection ability. As shown in Figure 3b, I still
mediated higher luciferase expression than H8, despite
the latter having a greater buffering capacity. This may
be because the process of endosomal escape, albeit
important, is just one of the several possible limiting
steps encountered by the DNA complex en route to
the nucleus. DNA release, for instance, may be another
potential limitation. To test this, we conducted FRET
experiments comparing peptides I and H8. For this
study, plasmids encoding for luciferase were double-
labelled with the FRET pair Cy3 (donor) and Cy5
(acceptor). During live-cell imaging, only Cy3 was excited
but emissions from both Cy3 and Cy5 were collected.
When the DNA is condensed, Cy3 and Cy5 are close
enough for FRET to occur (46). Upon complex dissoci-
ation and DNA uncondensation, FRET is reduced and
only Cy3 is detected. Each image was binary-scored
according to the number of pixels positive for Cy 3
(green) or Cy5 (false-coloured red). The ratio of red to
green pixels (R/G) was then used to indicate the extent
of FRET.
Figure 4 shows that at 6 h post-exposure, strong
co-localization of red and green signals were observed
in cells transfected with either H8 (R/G=0.81) or I
(R/G=0.84). This suggests that the DNA remained
condensed, presumably by the peptides up to this point.
After 25 h, however, FRET was largely unobservable in
cells transfected with I (R/G=0.04), whereas significant
FRET can still be seen in cells transfected with H8
(R/G=0.40). This suggests that DNA release from H8
complexes is indeed more difficult compared to I
complexes and may contribute to the lower luciferase
expression achieved with H8.
Based on luciferase expression results, two of the best
peptides (F and I) were selected to deliver plasmids
encoding for GFP into MCEC. Flow cytometry was
then used to quantify the percentage of cells that expressed
GFP. As shown in Figure 5a, F and I were generally com-
parable and more efficient (>5) than PEI in inducing
GFP expression in MCEC. However, although peptide I
seemed to perform better than F at N/P 25, the toxicity of
I complexes was higher, as shown in Supplementary
Figure S3. At N/P 20 and 25, for instance, the viability
of cells transfected with I complexes was 70% and
65%, respectively, compared to viabilities of 90%
and 80% with F complexes. Hence, peptide F at N/P
20 (peptide concentration in medium 32 mM) was
selected for all further work.
Cy 5 Cy 3 Merge BF + Hoe 
H8
25 hrs 
I
25 hrs 
H8
6 hrs 
I
6 hrs 
R/G = 0.81  
R/G = 0.84  
R/G = 0.40  
R/G = 0.04  
Figure 4. MCEC were exposed to peptide I or H8/DNA complexes (N/P 20) formed at pH 7.0. FRET was used to show if the DNA was still
condensed at selected time points. The DNA had been double-labelled with both Cy5 and Cy3. During imaging, only Cy3 was excited. If there was
FRET, Cy5 (false-coloured red) can also be detected, which will then co-localize with Cy3 (green) to give yellow signals in the merged image. All cells
were stained for their nuclei with Hoechst (Hoe) and presented with the bright field (BF) images.
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GFP expression can be observed in MCEC up to a
period of 14 days post-transfection with peptide F at
N/P 20 (Figure 5b). The number of GFP positive cells
(but not necessarily the proportion) appeared to increase
and then decrease, consistent with cell proliferation and
death. Due to technical limitations, however, it was not
possible to quantify the percentage of cell population
expressing GFP upon prolonged incubation.
The presence of serum during transfection significantly
augmented both luciferase (Supplementary Figure S4a)
and GFP (Supplementary Figure S4b) expression
mediated by peptide F, despite reports to the contrary
with other arginine-rich vectors (47). This may be due to
the enhanced viability of cells in the presence of serum
(Supplementary Figure S4a). This finding is particularly
useful for our future application as it is preferable to
culture whole corneas in the presence of serum throughout
the ex vivo manipulation. Additionally, we observed that
the expression level can be further increased with
prolonged exposure of MCEC to the complexes. For
instance, increasing the incubation period from 4 to 6 h
produced a 2.5 times increment in the amount of luciferase
expressed (Supplementary Figure S5).
The pH used for complex formation also influenced the
properties of the vector. It was observed that DNA bind-
ing became increasingly efficient as pH was reduced from
7.0 to 5.0, as shown by an ethidium bromide exclusion
assay (Supplementary Figure S6a). This was consistent
with the more extensive protonation of histidine at a
lower pH. However, the level of luciferase expression
mediated by complexes formed at pH 7.0 was significantly
higher than those formed at pH 6.3 or 5.0 (Supplementary
Figure S6b). FRET experiments then indicated that
decondensation of DNA within the cells was slower
with complexes formed at pH 5.0 (R/G=0.70 at 25 h
post-transfection) compared to those formed at pH 7.0
(R/G=0.28 at 25 h post-transfection), possibly contri-
buting to their lower transfection ability (Supplementary
Figure S7).
Having justified the tri-block design and demonstrated
the ability of the peptides to deliver genetic cargoes effi-
ciently into MCEC, we next investigated the mechanism(s)
by which the peptide complexes were internalized by
MCEC. The pathways of cellular uptake can be broadly
divided into those that are energy dependent or
independent. Endocytosis, which is energy-dependent,
is by far the best understood and can be further sub-
categorized into clathrin-mediated endocytosis, caveolae/
lipid raft-mediated endocytosis (simply referred to as
caveolae-mediated endocytosis hereon), macropinocytosis
and clathrin- and caveolae-independent endocytosis (48).
The exact internalization mechanism of arginine-
rich peptides (including HIV-Tat derived peptides) is con-
troversial. Energy dependent (29,30,49–52), energy inde-
pendent (53,54) and a combination of energy-dependent
and -independent pathways (depending on the concentra-
tion of peptide present) (55), have all been implicated
as possible internalization pathways for arginine-rich
peptides. In fact, just within the realm of endocytosis,
the clathrin-mediated pathway (52), caveolae-mediated
pathway (30) and macropinocytosis (29) had each been
individually identified as the main route of entry, while
others claim that a combination of several pathways was
more likely (50). Reasons for the apparent discrepancy
include factors such as differing experimental conditions,
sequence of peptide used and lineage of cells studied.
Care should also be taken when drawing conclusions
based on inhibitors that may affect more than one path-
way concurrently. We thus investigated the possible
route(s) by which MCEC internalize the peptide/DNA
complexes.
We co-cultured the cells with peptide F complexes (N/P
20) containing rhodamine-labelled DNA and either one of
the fluorescently labelled makers for specific pathways of
endocytosis: namely, transferrin, cholera toxin or dextran,
which are known to be internalized exclusively via the
clathrin-mediated pathway (49,56,57), caveolae-mediated
pathway (27) and macropinocytosis (55,58), respectively.
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Figure 5. (a) Percentage of MCEC expressing GFP 2 days post-transfection with peptides I, F or PEI. (b) Confocal images showing MCEC
expressing GFP up to 14 days post-transfection with F/DNA complexes (N/P 20). Each image is a merger of several z-stack images acquired as
the cell layers became overly confluent with the long incubation period. Cells also started to detach from the culture chambers after prolonged
incubation, explaining the apparent reduction in cells expressing GFP on day 14.
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After a brief incubation, cells were washed extensively
with PBS and observed for any co-localization of the
complexes and endocytosis markers. Cells were observed
live to avoid artefacts due to fixation (49). Interestingly,
we observed that the complexes exhibited partial
co-localization with all three endocytosis markers
(Figure 6). This suggests that all three mechanisms could
contribute to the uptake of peptide complexes by MCEC,
which seems reasonable in light of the heterogeneity of the
complex particles.
Involvement of the clathrin-mediated pathway—whose
vesicles undergo acidification (48,58,59), unlike caveo-
somes (30,40,58,60) and macropinosomes (29,58,59)
which remain neutral—was also supported by the obser-
vation that chloroquine increased luciferase expression
by 3.5- to 7.6-fold (Supplementary Figure S8). This is con-
sistent with the ability of chloroquine to promote
endosomal rupture and cytosolic escape by the prevention
of acidification (31,44).
To provide further evidence for the involvement of
different endocytotic pathways, we quantified the effects
of various inhibitors on MCEC at both the uptake
(Figure 7a) and gene expression (Figure 7b) level. This
then allows discrimination of which pathway is most bio-
logically relevant, as efficient internalization may not
necessarily lead to high expression. All data shown were
normalized to cells transfected in the presence of vehicle
control (DMSO or water) alone.
The combination of NaN3/DOG blocks intracellular
ATP synthesis and inhibits all forms of energy-dependent
translocation (41). Since incubating the cells with NaN3/
DOG drastically reduced their ability to endocytose
(87.7% inhibition) and express the gene (98.2%
inhibition), this confirms that energy-dependent endocyto-
sis is the main form of uptake relevant to this system.
Live-cell confocal observations further demonstrated
the impaired uptake upon NaN3/DOG treatment
(Supplementary Figure S9). Results from both flow
cytometry and confocal microscopy also show that
surface-adsorbed particles have been adequately removed
in all experiments.
The actin cytoskeleton (required during the early
budding process of vesicles near the cell surface),
GTPase dynamin (known to mediate the budding of
pits) and microtubules (required for the subsequent
trafficking of budded vesicles) are all reported to be
important for the trafficking of endosomes, caveosomes
and macropinosomes (27,48,61,62). Furthermore, both
the clathrin- and caveolae-mediated pathways have been
shown to be sensitive to cholesterol depletion (52,62,63).
Treatment of the cells with cytochalasin [which disrupts
the actin cytoskeleton (56)], dynasore [which inhibits the
GTPase activity of dynamin (28)], nocodazole [which
disrupts microtubule depolymerization (26)] and methyl-
b-cyclodextrin [MbCD, which extracts cholesterol from
cell membrane (63)] significantly reduced uptake by
58.5%, 64.7%, 58.2% and 41.9%, respectively. Gene
expression also dropped by 89.3% and 35.0% after
cytochalasin and MbCD treatment, respectively. The
effects of dynasore on gene expression cannot be examined
F Tfr Merge Hoechst + BF 
MergeDex F
MergeCT-B F
Figure 6. Co-localization (yellow) of F peptide complexed with DNA (red) at N/P 20 with classical markers for specific endocytosis pathways like
transferrin (Tfr, green) for clathrin-mediated endocytosis, cholera toxin B (CT-B, green) for caveolae/lipid raft-mediated endocytosis and dextran
(Dex, false-coloured green) for macropinocytosis. Cells were all stained with the Hoechst nuclear dye (blue) and presented with the bright field (BF)
images. Imaging was done 40–90min post-exposure to peptide/DNA complexes.
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due to its pronounced toxicity during the longer incuba-
tion period used for gene expression assays. Nocodazole,
on the other hand, increased gene expression 2.35 times.
A possible reason may be due to the disruption of the
microtubule network and therefore, late-stage trafficking.
For instance, it was reported that in nocodazole-treated
cells, internalized molecules remained sequestered longer
within early endosomes (64). The delay in maturation into
digestive lysosomes may mean that the complexes have
more opportunity to escape into the cytosol, in turn
increasing the chance of their genetic cargoes being
expressed.
The involvement of both the caveolae-mediated path-
way and macropinocytosis is given further credit by
using inhibitors that shuts down the respective pathways.
Filipin is an inhibitor of the caveolae-mediated pathway
(26,27,54,57,63) and treatment with this drug reduced
uptake and gene expression by 48.6% and 88.4%,
respectively. Similarly, 5-(N-ethyl-N-isopropyl)amiloride
(EIPA), an inhibitor of macropinocytosis (29,50,55),
reduced uptake and expression by 32.9% and 75.1%,
respectively, though it is recognized that the action of
these inhibitors may not be totally specific.
Cell-surface proteoglycans, in particular, heparan sul-
phate (HS) have been reported to be key mediators in
the initial binding events leading to internalization
(58,65,66). Our results suggest that interaction with HS
indeed seems pivotal for internalization as the presence
of heparin, which competes with HS for binding with
the complexes, dramatically reduced uptake (of which
it may the binding process that is blocked, and not
internalization) and luciferase expression by 91.4% and
99.9%, respectively. The concentration of heparin used
for this experiment (50mg/ml) is not expected to affect
the stability of the complexes (Figure 2c).
Recently, it was demonstrated that particles as large as
3 mm can still be internalized by non-phagocytic cells using
endocytotic pathways (41), suggesting that the actual size
cut-off limit for internalization may be larger than previ-
ously thought. Although the peptide F complexes are
larger than 3 mm, it is possible that their internalization
involves fragmentation into smaller ‘bite-size’ pieces. This
fragmentation process has been observed during macro-
pinocytosis and the pinching-off of membrane vesicles (67).
While the previous confocal studies determined the
locality of the DNA, they gave no information as to
whether the DNA remained condensed. To address this,
we conducted FRET experiments, this time involving
peptide F and MCEC using earlier time points and
analysing more closely cellular localization. Figure 8a
shows that strong co-localization of Cy3 and Cy5
(R/G=0.92) can be observed up to 4.5 h after
transfection, indicating that the DNA was still condensed,
presumably by the peptide carrier. There was also evi-
dence of early stage nuclear entry of condensed DNA,
as indicated by the co-localization of yellow and blue
Hoechst signals. This suggests that the peptide/DNA
entered the nucleus as an associated complex. Similar
nuclear entry of PEI/DNA complexes has been pre-
viously reported, albeit at different time-points post-
transfection (68).
By 8.5 h, however, there was evidence of DNA
uncondensing, as shown by a decrease in the red Cy 5
signal (Figure 8b). The merged image therefore appears
more green than yellow (R/G=0.41). By 26 h, large
amount of DNA had accumulated within the nuclei
which showed little FRET signal (R/G=0.05) and so
was presumably not condensed (Figure 8c). Figure 8d
focuses on a nucleus at 26 h exhibiting large-scale accu-
mulation of uncondensed DNA (R/G=0.00). Finally, to
ensure that the disappearance of Cy5 signals was due to a
lost of FRET and not simply an artefact of photobleach-
ing or degradation, we excited with the Cy5 wavelength
alone, which resulted in the complete disappearance of
Cy3 signals and appearance of Cy5 fluorescence (data
not shown).
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Figure 7. Effects of various inhibitors on the (a) uptake and (b) gene expression of MCEC transfected with F complexes (N/P 20). Cells were pre-
incubated with inhibitors for 1 h prior to exposure to F complexes containing Cy5-labelled DNA (for uptake quantification using flow cytometry) or
unlabelled DNA (for gene expression). Values were all referenced to control cells normally transfected with F complexes without any inhibitors
(assigned as 100%). In cases whereby the inhibitors had to be dissolved in DMSO, control cells were also transfected in the presence of the same
volume of pure DMSO. Error bars represent SD.
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To demonstrate biological relevance, we next used the
peptides to deliver plasmids encoding for IDO into
MCEC. IDO is a cytosolic haem-containing enzyme
which catalyses the biodegradation of tryptophan down
the kynurenine pathway (69). Since the growth of T
lymphocytes are critically dependent on tryptophan—
without which they get arrested in their G1 phase (70)—
it has been shown that IDO overexpression can suppress
T-cell responses (71,72). In the context of corneal
transplantation, the induction of IDO expression in the
corneal endothelium prolongs allograft survival by locally
suppressing T-cell activity (12).
We first transfected MCEC with peptide F complexed
with plasmids encoding for IDO. IDO mRNA expression
normalized to the housekeeping HPRT gene was then
quantified using RT–PCR (Figure 9a). As can be seen,
there was a strong increase (>105 fold) in the level of
IDO mRNA following peptide-mediated transfection,
compared to untransfected and mock-transfected (GFP)
MCEC. More significantly, the levels of IDO mRNA
expression induced by peptide F were also higher (by
up to 17-fold) than those induced by PEI or
lipofectamineTM2000. IDO protein was also detected by
western blotting after cells have been transfected with
peptide F/IDO complexes (Figure 9b).
(b)
(c)
(d)
(a)
Merge BFCy 5
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Nucleus
R/G = 0.92  
R/G = 0.41  
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Cy 3 
Figure 8. FRET study. Confocal images taken of live MCEC at row (a) 4.5 h, row (b) 8.5 h and row (c) 26 h after initial exposure to peptide F/DNA
complexes at N/P 20. The DNA had been double-labelled with both Cy5 and Cy3. During imaging, only Cy3 was excited. If there was FRET, Cy5
(false-coloured red) can also be detected, which will then co-localize with Cy3 (green) to give yellow signals in the merged image. Row (d) A nucleus
at 26 h showing large scale accumulation of uncondensed DNA. All cells were stained for their nuclei with Hoechst (blue) and presented with the
bright field (BF) images.
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Figure 9. (a) IDO mRNA expression in MCEC transfected with
peptide F, PEI or lipofectamineTM2000 (LF). Negative controls include
untransfected MCEC (Blank) or mock transfection with F/GFP
complexes (GFP) at N/P 30. Error bars represent standard deviation.
(b) IDO protein expression detected by western blot following transfec-
tion with peptide F at N/P ratios 15–30. Mock transfection with
F/GFP complexes (GFP) at N/P 30 served as the negative control.
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To show that the IDO expressed by the cells retained
functional activity, the amount of L-kynurenine, the main
breakdown product of tryptophan (73), in the culture
supernatant was measured (Figure 10a). As can be seen,
the levels of L-kynurenine detected in the supernatant of
MCEC transfected with peptide F were elevated compared
to untransfected and mock-transfected controls. The
IDO produced by the cells was therefore biologically
functional. Further, the levels of L-kynurenine detected
were reduced significantly, though to a variable extent,
by the addition of 1-MT, an inhibitor of IDO (70–72).
This showed that the effect of L-kynurenine production
was due to IDO activity.
CD4+ T-cells are the chief mediator of ocular inflam-
mation (2). It was therefore important to evaluate the
effect of IDO production on the proliferation of CD4+
T-cells. To achieve this, peptide-transfected MCEC was
incubated with CD4+ responder T cells freshly isolated
from the spleens of C3H mice and stimulated with anti-
CD3 and CD28 beads. The proliferation of the T cells was
then measured by [3H]thymidine incorporation after
a 3-day period. It was observed that the proliferative
ability of T-cells incubated with IDO-transfected
MCEC, but not GFP-transfected MCEC, was reduced
by up to 70% compared to the untransfected MECE
control (Figure 10b). Further, the inhibitory effect was
reversed by the addition of 1-MT. These data showed
that the suppressed growth of T cells was specifically
due to the effects of IDO activity, offering us a promising
strategy to apply in the ex vivo manipulation of whole
corneas for our future work.
CONCLUSION
In summary, we have demonstrated that the tri-block
arginine-rich oligopeptides were more effective than PEI
in mediating the expression of reporter (luciferase and
GFP) and therapeutic (IDO) genes in MCEC. The pres-
ence of a hydrophobic block and a buffering component
within the tri-block design were systematically shown
to be important in influencing the transfection perform-
ance of the peptide. We elucidated the pathways of intern-
alization and showed that the MCEC mainly utilized
energy-dependent endocytosis where internalization was
heavily dependent on interactions with cell-surface HS.
Additionally, distinct pathways such as the clathrin-
mediated endocytosis, caveolae-mediated endocytosis
and macropinocytosis all contributed to the eventual
uptake, although none of the pathways seemed to dom-
inate. FRET studies demonstrated that the DNA entered
cells as a condensed complex. Events after uptake, for
instance, DNA uncondensation (by 8.5 h) and the accu-
mulation of free DNA within nuclei (by 26 h) were
demonstrated. We have also shown that we can use the
peptides to deliver plasmids encoding for a biologically
relevant protein, IDO, that has previously been shown
to prolong corneal allograft survival (12). IDO expression
was then detected at the mRNA and protein level and
shown to be functionally active and capable of inhibiting
T-cell proliferation. Although transfection efficiency may
depend on the size and nature of plasmids used, we have
shown that the peptides were able to deliver plasmids
ranging in size from 4.7 to 8.5 kb. This class of non-viral
vector therefore promises to be a versatile vehicle for the
immunomodulation of corneal transplantations.
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Supplementary Data are available at NAR Online.
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Figure 10. IDO functional assays. (a) Levels of L-kynurenine detected in the supernatants of MCEC transfected with F/IDO complexes, F/GFP
complexes (GFP) at N/P 30 or untransfected (MCEC). The addition of the specific IDO antagonist, 1-MT, reduced the catalytic activity of IDO and
the amount of L-kynurenine detected by varying degrees. (b) CD4+ T-cells were either incubated alone (T-cells) or with MCEC in a 3-day prolif-
eration assay. The proliferation rate of CD4+ T-cells was then assessed by [3H]thymidine incorporation. MCEC used were either untransfected
(MCEC), or transfected with IDO (F/IDO) or GFP (F/GFP) using peptide F at N/P 30. The addition of 0.75mM of 1-MT (F/IDO+1-MT) reversed
the inhibiting effects of IDO activity. All error bars represent SD.
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